Indanone: a promising scaffold for new drug discovery against neurodegenerative disorders

被引：2

作者：

Bansal, Ranju ^{[1
]}

Singh, Ranjit ^{[1
]}

Dutta, Tuhin Shubra ^{[1
]}

Dar, Zahid Ahmad ^{[1
]}

Bajpai, Ankit ^{[1
]}

机构：

[1] Panjab Univ, Univ Inst Pharmaceut Sci UIPS, Chandigarh 160014, India

来源：

DRUG DISCOVERY TODAY | 2024年 / 29卷 / 08期

关键词：

indanone; Alzheimer ' s disease; Parkinson ' s disease; monoamine oxidases (MAO); acetylcholinesterase (AChE); molecular docking; TARGETING ALZHEIMERS-DISEASE; ALPHA-TETRALONE DERIVATIVES; MONOAMINE-OXIDASE; ACETYLCHOLINESTERASE INHIBITORS; ANTIINFLAMMATORY DRUGS; PHARMACOLOGICAL EVALUATION; RECEPTOR ANTAGONIST; OXIDATIVE STRESS; ISCHEMIC-STROKE; DESIGN;

D O I：

10.1016/j.drudis.2024.104063

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Indanone is a versatile scaffold that has a number of pharmacological properties. The successful development and ensuing approval of indanone-derived donepezil as a drug of choice for Alzheimer ' s disease attracted signi ficant scienti fic interest in this moiety. Indanones could act as small molecule chemical probes as they have strong af finity towards several critical enzymes associated with the pathophysiology of various neurological disorders. Inhibition of these enzymes elevates the levels of neuroprotective brain chemicals such as norepinephrine, serotonin and dopamine. Further, indanone derivatives are capable of modulating the activities of both monoamine oxidases (MAO-A and-B) and acetylcholinesterase (AChE), and thus could be useful in various neurodegenerative diseases. This review article presents a panoramic view of the research carried out on the indanone nucleus in the development of potential neuroprotective agents.

引用

页数：15

共 97 条

[51] Monoamine oxidase inhibitory activities of heterocyclic chalcones [J].

Minders, Corne ;

Petzer, Jacobus P. ;

Petzer, Anel ;

Lourens, Anna C. U. .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (22) :5270-5276

[52] Synthesis, Biological Evaluation, and Molecular Simulation of Chalcones and Aurones as Selective MAO-B Inhibitors [J].

Morales-Camilo, Nicole ;

Salas, Cristian O. ;

Sanhueza, Claudia ;

Espinosa-Bustos, Christian ;

Sepulveda-Boza, Silvia ;

Reyes-Parada, Miguel ;

Gonzalez-Nilo, Fernando ;

Caroli-Rezende, Marcos ;

Fierro, Angelica .

CHEMICAL BIOLOGY & DRUG DESIGN, 2015, 85 (06) :685-695

[53] Indanones As High-Potency Reversible Inhibitors of Monoamine Oxidase [J].

Mostert, Samantha ;

Petzer, Anel ;

Petzer, Jacobus P. .

CHEMMEDCHEM, 2015, 10 (05) :862-873

[54] The basis of cellular and regional vulnerability in Alzheimer's disease [J].

Mrdjen, Dunja ;

Fox, Edward J. ;

Bukhari, Syed A. ;

Montine, Kathleen S. ;

Bendall, Sean C. ;

Montine, Thomas J. .

ACTA NEUROPATHOLOGICA, 2019, 138 (05) :729-749

[55] 2-Heteroarylidene-1-indanone derivatives as inhibitors of monoamine oxidase [J].

Nel, Magdalena S. ;

Petzer, Anel ;

Petzer, Jacobus P. ;

Legoabe, Lesetja J. .

BIOORGANIC CHEMISTRY, 2016, 69 :20-28

[56] 2-Benzylidene-1-indanone derivatives as inhibitors of monoamine oxidase [J].

Nel, Magdalena S. ;

Petzer, Anel ;

Petzer, Jacobus P. ;

Legoabe, Lesetja J. .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (19) :4599-4605

[57]

Novelli G P, 1986, Free Radic Res Commun, V1, P321, DOI 10.3109/10715768609080971

[58] From epidemiology to therapeutic trials with anti-inflammatory drugs in Alzheimer's disease: The role of NSAIDs and cyclooxygenase in β-amyloidosis and clinical dementia [J].

Pasinetti, Giulio Maria .

JOURNAL OF ALZHEIMERS DISEASE, 2002, 4 (05) :435-445

[59] Recent developments in biological activities of indanones [J].

Patil, Siddappa A. ;

Patil, Renukadevi ;

Patil, Shivaputra A. .

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 138 :182-198

[60]

Pihlstrom L, 2018, HAND CLINIC, V145, P309, DOI 10.1016/B978-0-12-802395-2.00022-5

← 1 2 3 4 5 6 7 8 9 10 →